190 related articles for article (PubMed ID: 37479567)
1. Functional characterization of CYP1 enzymes: Complex formation, membrane localization and function.
Connick JP; Reed JR; Cawley GF; Saha A; Backes WL
J Inorg Biochem; 2023 Oct; 247():112325. PubMed ID: 37479567
[TBL] [Abstract][Full Text] [Related]
2. Heme oxygenase-1 affects cytochrome P450 function through the formation of heteromeric complexes: Interactions between CYP1A2 and heme oxygenase-1.
Connick JP; Reed JR; Cawley GF; Backes WL
J Biol Chem; 2021; 296():100030. PubMed ID: 33148696
[TBL] [Abstract][Full Text] [Related]
3. The Localization of Cytochrome P450s CYP1A1 and CYP1A2 into Different Lipid Microdomains Is Governed by Their N-terminal and Internal Protein Regions.
Park JW; Reed JR; Backes WL
J Biol Chem; 2015 Dec; 290(49):29449-60. PubMed ID: 26468279
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Interactions Among CYP1A2, CYP2B4, and NADPH-cytochrome P450 Reductase: Identification of Specific Protein Complexes.
Connick JP; Reed JR; Backes WL
Drug Metab Dispos; 2018 Mar; 46(3):197-203. PubMed ID: 29233819
[TBL] [Abstract][Full Text] [Related]
5. Heteromeric complex formation between human cytochrome P450 CYP1A1 and heme oxygenase-1.
Connick JP; Reed JR; Cawley GF; Backes WL
Biochem J; 2021 Jan; 478(2):377-388. PubMed ID: 33394027
[TBL] [Abstract][Full Text] [Related]
6. Basal and inducible CYP1 mRNA quantitation and protein localization throughout the mouse gastrointestinal tract.
Uno S; Dragin N; Miller ML; Dalton TP; Gonzalez FJ; Nebert DW
Free Radic Biol Med; 2008 Feb; 44(4):570-83. PubMed ID: 17997381
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human CYP1 enzymes by a classical inhibitor α-naphthoflavone and a novel inhibitor N-(3, 5-dichlorophenyl)cyclopropanecarboxamide: An in vitro and in silico study.
Juvonen RO; Jokinen EM; Javaid A; Lehtonen M; Raunio H; Pentikäinen OT
Chem Biol Drug Des; 2020 May; 95(5):520-533. PubMed ID: 32060993
[TBL] [Abstract][Full Text] [Related]
8. Novel cytochrome P450 1 (CYP1) genes in tree shrews are expressed and encode functional drug-metabolizing enzymes.
Uno Y; Noda Y; Murayama N; Tsukiyama-Kohara K; Yamazaki H
Comp Biochem Physiol C Toxicol Pharmacol; 2023 Mar; 265():109534. PubMed ID: 36563947
[TBL] [Abstract][Full Text] [Related]
9. Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences.
Iwanari M; Nakajima M; Kizu R; Hayakawa K; Yokoi T
Arch Toxicol; 2002 Jun; 76(5-6):287-98. PubMed ID: 12107646
[TBL] [Abstract][Full Text] [Related]
10. The Influence of Lipid Microdomain Heterogeneity on Protein-Protein Interactions: Proteomic Analysis of Co-Immunoprecipitated Binding Partners of P450 1A2 and P450 3A in Rat Liver Microsomes.
Reed JR; Guidry JJ; Eyer M; Backes WL
Drug Metab Dispos; 2023 Sep; 51(9):1196-1206. PubMed ID: 37349115
[TBL] [Abstract][Full Text] [Related]
11. Effect of homomeric P450-P450 complexes on P450 function.
Reed JR; Connick JP; Cheng D; Cawley GF; Backes WL
Biochem J; 2012 Sep; 446(3):489-97. PubMed ID: 22738171
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin.
Chang TK; Chen J; Yang G; Yeung EY
J Pineal Res; 2010 Jan; 48(1):55-64. PubMed ID: 19919601
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 system proteins reside in different regions of the endoplasmic reticulum.
Park JW; Reed JR; Brignac-Huber LM; Backes WL
Biochem J; 2014 Dec; 464(2):241-9. PubMed ID: 25236845
[TBL] [Abstract][Full Text] [Related]
14. Dihydrotanshinone I-Induced CYP1 Enzyme Inhibition and Alteration of Estradiol Metabolism.
Liu Y; Chen Y; Zhang J; Ran G; Cheng Z; Wang X; Liao Y; Mao X; Peng Y; Li W; Zheng J
Drug Metab Dispos; 2024 Feb; 52(3):188-197. PubMed ID: 38123940
[TBL] [Abstract][Full Text] [Related]
15. Identification of the contact region responsible for the formation of the homomeric CYP1A2•CYP1A2 complex.
Saha A; Connick JP; Reed JR; Lott CS; Backes WL
Biochem J; 2021 Jun; 478(11):2163-2178. PubMed ID: 34032264
[TBL] [Abstract][Full Text] [Related]
16. Relationship between CYP1A2 localization and lipid microdomain formation as a function of lipid composition.
Brignac-Huber LM; Reed JR; Eyer MK; Backes WL
Drug Metab Dispos; 2013 Nov; 41(11):1896-905. PubMed ID: 23963955
[TBL] [Abstract][Full Text] [Related]
17. Molecular modelling of CYP1 family enzymes CYP1A1, CYP1A2, CYP1A6 and CYP1B1 based on sequence homology with CYP102.
Lewis DF; Lake BG; George SG; Dickins M; Eddershaw PJ; Tarbit MH; Beresford AP; Goldfarb PS; Guengerich FP
Toxicology; 1999 Nov; 139(1-2):53-79. PubMed ID: 10614688
[TBL] [Abstract][Full Text] [Related]
18. Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2.
Chang TK; Chen J; Lee WB
J Pharmacol Exp Ther; 2001 Dec; 299(3):874-82. PubMed ID: 11714871
[TBL] [Abstract][Full Text] [Related]
19. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
[TBL] [Abstract][Full Text] [Related]
20. Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: substrate specificity with model substrates and promutagens.
Crespi CL; Penman BW; Steimel DT; Smith T; Yang CS; Sutter TR
Mutagenesis; 1997 Mar; 12(2):83-9. PubMed ID: 9106248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
